Stay Consistent Weight loss takes time, even with Semaglutide
The TRIUMPH cardiovascular outcomes trial will determine whether these surrogate marker improvements translate to fewer actual cardiovascular events
Medicare Part D cannot cover Wegovy for weight loss because federal law prohibits Medicare from covering weight loss medications, and Medicare beneficiaries cannot use manufacturer savings programs
Individuals should be encouraged to consume meals at regular intervals, as prolonged fasting without adequate protein intake or dietary variety may increase the risk of nutritional inadequacy
Keeping a detailed symptom diary and using objective markers like fecal calprotectin testing helps distinguish between medication effects and disease activity
Plans will include monitoring patients for signs of SSRI toxicity or reduced efficacy, weakening medication dosages accordingly, and considering other treatment options if necessary